Cefalexin 250mg capsules

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Cefalexin

Available from:

Actavis UK Ltd

ATC code:

J01DB01

INN (International Name):

Cefalexin

Dosage:

250mg

Pharmaceutical form:

Oral capsule

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 05010201; GTIN: 5012617009029

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
CEFALEXIN CAPSULES 250 MG
CEFALEXIN CAPSULES 500 MG
(cefalexin monohydrate)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you. Do not pass it on
to
others. It may harm them, even if their symptoms are the
same as yours.
-
If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor.
IN THIS LEAFLET:
1. What Cefalexin Capsules are and what they are used for
2. Before you take Cefalexin Capsules
3. How to take Cefalexin Capsules
4. Possible side effects
5. How to store Cefalexin Capsules
6. Further information
1. WHAT CEFALEXIN CAPSULES ARE AND WHAT THEY ARE
USED FOR
Cefalexin Capsules contain cefalexin as the active ingredient, which
belongs to a class of antibiotics called ‘cephalosporins’. The
capsules
are used to treat a variety of bacterial infections. These include
infections of the airways from nose to lungs, ear, bones and joints,
and urine or reproduction systems, incuding inflammation of the
prostate gland. They are also used to treat dental infections.
2. BEFORE YOU TAKE CEFALEXIN CAPSULES
DO NOT TAKE CEFALEXIN CAPSULES IF YOU HAVE:
•
an allergy (hypersensitivity) to the cephalosporin or penicillin
group of antibiotics, or to any of the ingredients in the product
_(see Section 6)._
•
porphyria; a hereditary metabolic disorder.
TAKE SPECIAL CARE WITH CEFALEXIN CAPSULES IF YOU HAVE:
•
kidney problems.
•
inflammation of the large intestine, symptoms include:
diarrhoea, pain and fever.
You should be aware that Cefalexin Capsules may give a false result
for:
•
certain blood tests
•
tests for glucose in the urine.
TAKING OTHER MEDICINES
Please inform your doctor if you are taking or have recently taken
any other medicines, including those obtained without a
prescription.
In particular, tell your doctor i

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Cefalexin 250 mg Capsules
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains Cefalexin monohydrate equivalent to 250 mg
Cefalexin
For a full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Capsules, hard
Size 2 grey/orange capsule containing white powder printed CHX 250.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cefalexin is indicated in the treatment of the following infections
due to
susceptible micro-organisms: respiratory tract infections; otitis
media; skin
and soft tissue infections; bone and joint infections; genito-urinary
infections,
including acute prostatitis; dental infections.
Cefalexin is active against the following organisms in vitro:
beta-haemolytic
streptococci; staphylococci, including coagulase-positive,
coagulase-negative
and penicillinase-producing strains; streptococcus pneumoniae;
escherichia
coli; proteus mirabilis; klebsiella species, haemophilus influenzae;
branhamella catarrhalis.
Most strains of enterococci (streptococcus faecalis) and a few strains
of
staphylococci are resistant to cefalexin. It is not active against
most strains of
enterobacter species, morganella morganii and pr. Vulgaris. It has no
activity
against pseudomonas or herellea species. When tested by in vitro
methods,
staphylococci exhibit cross-resistance between cefalexin and
methicillin-type
antibiotics.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Adults _
The adult dosage ranges from 1-4g daily in divided doses; most
infections will
respond to a dosage of 500mg every 8 hours. For skin and soft tissue
infections, streptococcal pharyngitis and mild, uncomplicated urinary
tract
infections, the usual dosage is 250mg every 6 hours, or 500mg every 12
hours.
For more severe infections or those caused by less susceptible
organisms,
larger doses may be needed. If daily doses of cefalexin greater than
4g are
required parenteral cephalosporins, in appropriate doses, should be
considered.
_Elderly _
As for adults. Reduce dosage i